Related Experiment Video
Updated: May 25, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptors
Micah L Burch1, Narin Osman, Robel Getachew
1BakerIDI Heart and Diabetes Institute, Commercial Road, Melbourne, Victoria 3004, Australia.
Abstract:
The current paradigm of G protein coupled receptor signaling involves a classical pathway being the activation of phospholipase C and the generation of 1,4,5-inositol trisphosphate, signaling through β-arrestin scaffold molecules and the transactivation of tyrosine kinase growth factor receptors. Transactivation greatly expands the range of signaling pathways and responses attributable to the receptor. Recently it has been revealed that G protein coupled receptor agonists can also transactivate the serine/threonine kinase cell surface receptor for transforming growth factor-β (Alk5). This leads to the generation of carboxyl terminal phosphorylated Smad2 which is the immediate downstream product of the activated Alk5. Thus, the current paradigm of G protein coupled signaling can be expanded to include the transactivation of the serine kinase receptor Alk5. These insights expand the possibilities for outcomes of therapeutically targeting GPCRs where more substantive and prolonged actions such as the synthesis of extracellular matrix may be affected.
Insights
G protein-coupled receptor (GPCR) signaling now includes transactivation of the transforming growth factor-β receptor (Alk5). This expands understanding of GPCR actions and therapeutic targeting, potentially affecting extracellular matrix synthesis.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Pharmacology
Background:
- G protein-coupled receptor (GPCR) signaling classically involves phospholipase C activation and β-arrestin mediated transactivation of tyrosine kinase receptors.
- Recent findings indicate GPCR agonists can also transactivate serine/threonine kinase receptors.
Purpose of the Study:
- To expand the current paradigm of G protein-coupled receptor signaling.
- To investigate the transactivation of the transforming growth factor-β receptor (Alk5) by GPCR agonists.
Main Methods:
- The study focuses on the molecular mechanisms of GPCR signaling and receptor transactivation.
- Analysis of downstream signaling events following Alk5 activation.
Main Results:
- GPCR agonists were shown to transactivate the serine/threonine kinase receptor Alk5.
- This transactivation leads to the generation of carboxyl-terminal phosphorylated Smad2, a key downstream mediator of Alk5 signaling.
Conclusions:
- The paradigm of G protein-coupled receptor signaling should be expanded to include the transactivation of Alk5.
- These findings offer new possibilities for therapeutic targeting of GPCRs, potentially influencing prolonged cellular responses like extracellular matrix synthesis.
Related Concept Videos
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Amplifying Signals via Enzymatic Cascade
G-protein Coupled Receptors
G-protein Coupled Receptors

